Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajogmf.2022.100665 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Letter to the Editor on "Social Vulnerability is Associated with Worse Urinary Incontinence and Quality of Life in Women".
Urology
January 2025
Department of Urology, Vanderbilt University Medical Center, A-1302 MCN, 1161 21st Avenue, South, Nashville, TN 37232-2765. Electronic address:
In Reply to Fastner et al.
Pract Radiat Oncol
January 2025
Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, Ohio.
Reply to: "Comment on: Differences in Setting of Initial Dementia Diagnosis Among Fee-for-Service Medicare Beneficiaries".
J Am Geriatr Soc
January 2025
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
In Reply: What Are We Transfusing? Evaluating the Quality and Clinical Utility of Intraoperatively Salvaged Red Blood Cells in Spinal Deformity Surgery: A Nonrandomized Controlled Trial.
Neurosurgery
January 2025
Department of Neurosurgery, New York University Langone Medical Center, New York, New York, USA.
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.
Cancers (Basel)
December 2024
Division of Early Drug Development, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Background: Early-phase clinical trials offer a unique opportunity for patients with cancer. These trials often mandate biopsies to collect tumor tissue for research purposes, requiring patients to undergo invasive procedures. Some trials mandate molecular prescreening, but the success of these analyses relies on the quality and quantity of the tested materials.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!